CD79A and autoimmune polyendocrinopathy: [34, 48–50] Further multicenter cohort study studies with patients of various ethnicities are required, to definitively determine the association between the IgA-aB2GP1 and APS-events in asymptomatic population before recommending preventive treatment with anticoagulants or platelet antiagregants drugs.